Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 2/20 | 0.32 |
| ▸ | TUBB | P07437 | 2/20 | 0.32 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.32 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.32 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.32 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.32 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.32 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.32 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.32 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.32 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.32 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.32 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.32 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6995825 | 0.91 | — | — | |
| SCHEMBL5638953 | 0.86 | — | — | |
| SCHEMBL701014 | 0.82 | — | — | |
| SCHEMBL6982486 | 0.81 | — | — | |
| SCHEMBL6383393 | 0.81 | LMNA (0.34) | NQO2 | |
| SCHEMBL6989149 | 0.73 | — | — | |
| SCHEMBL6993796 | 0.73 | — | — | |
| SCHEMBL30480757 | 0.70 | ALOX15 (0.31) | — | |
| SCHEMBL5639859 | 0.69 | GAA (0.39) | NQO2 | |
| SCHEMBL6982039 | 0.69 | MAPT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7301034-B2 | Preparation of -4-thioalkybrobenzene derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-27 | — | — | US | claimed |
| EP-1301469-B1 | PREPARATION OF 4-THIOALKYLBROMOBENZENE DERIVATIVES | BASF AG (DE) | 2006-06-21 | — | — | EP | claimed |
| US-20030149276-A1 | Preparation of -4-thioalkybrobenzene derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-07 | — | — | US | claimed |
| US-7301034-B2 | Preparation of -4-thioalkybrobenzene derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-27 | — | — | US | disclosed |
| EP-1301469-B1 | PREPARATION OF 4-THIOALKYLBROMOBENZENE DERIVATIVES | BASF AG (DE) | 2006-06-21 | — | — | EP | disclosed |
| US-20030149276-A1 | Preparation of -4-thioalkybrobenzene derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149276-A1 | Preparation of -4-thioalkybrobenzene derivatives | CBR1, CBR3, AOC3 | TUBB4A 2170/4885TUBB 1439/4885TUBA3C 593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.